Mackenzie Financial
GMAB icon

Mackenzie Financial’s Genmab GMAB Stock Holding History

Mackenzie Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,060
Closed -$769K – 1731
2025
Q3 		$769K Sell
25,060
-6,850
-21% -$167K ﹤0.01% 1142
2025
Q2 		$659K Sell
31,910
-1,100
-3% -$22.6K ﹤0.01% 1128
2025
Q1 		$646K Hold
33,010
– – ﹤0.01% 1116
2024
Q4 		$689K Buy
+33,010
New +$725K ﹤0.01% 1045

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mackenzie Financial's GMAB Position: Q4 2025 in Review

Mackenzie Financial sold out of Genmab (GMAB) in Q4 2025, closing a stake of 25,060 shares — an estimated $769K sold.

Mackenzie Financial first reported a position in GMAB in Q4 2024 and held it in 4 quarters. The position peaked at $769K in Q3 2025. 293 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

  • Mackenzie Financial reported no remaining Genmab position as of Q4 2025 after selling out during the quarter.
  • Mackenzie Financial sold 25,060 Genmab shares in Q4 2025, an estimated $769K.
  • Mackenzie Financial first reported a position in Genmab in Q4 2024 and held it in 4 quarters.
  • Mackenzie Financial's Genmab position peaked at $769K in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on Mackenzie Financial's 13F filing for Q4 2025, filed 18 Feb 2026.